Founder & Executive Chairperson at Biocon
My best friend had to sell her property to afford oncology therapies that cost two and a half lakh rupees per dose. This inspired me to develop affordable copies of biologic drugs, leading to Biocon becoming the first company to receive US FDA approval for a trastuzumab biosimilar.
This answer is part of a full interview with Kiran Mazumdar-Shaw, Founder & Executive Chairperson at Biocon.
Found this insight valuable? Share it with your network to help others learn from Kiran Mazumdar-Shaw's experience.
Use this answer in your research, article, or academic work
